Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Neural Networks : the Official Journal of the International Neural Network Society|April 19, 2026
Comorbidity-aware transfer learning for neuro-developmental disorder diagnosisXin Wen, Shijie Guo, Li Dong, et al.
Oral Oncology|September 14, 2010
Feasibility and efficacy study of weekly cisplatin with concurrent intensity-modulated radiation therapy for nasopharyngeal carcinoma: preliminary resultsHeming Lu, Jiaxin Chen, Baoqin Huang, et al.
Cryobiology|December 8, 2023
Effects of intracellular Ca<sup>2+</sup> on developmental potential and ultrastructure of cryopreserved-warmed oocyte in mouseJunping Cheng, Xiaoli Wang, Chan Luo, et al.
Cancer Treatment Reviews|February 13, 2009
Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast AsiaHeming Lu, Luxing Peng, Xianbin Yuan, et al.
Case Reports in Oncology|August 27, 2010
Intrathoracic Endotracheal Metastasis from Nasopharyngeal Carcinoma: A First Case Report and Review of the LiteratureHeming Lu, Jiaxin Chen, Yanyan Xie, et al.
Romanian Journal of Morphology and Embryology = Revue Roumaine De Morphologie Et Embryologie|January 9, 2016
Overexpression of CSF-1R in nasopharyngeal carcinomaLi Huang, Ximing Xu, Yanrong Hao, et al.
International Journal of Oncology|January 24, 2012
Identification of prognostic biomarkers for response to radiotherapy by DNA microarray in nasopharyngeal carcinoma patientsShu Yang, Jiaxin Chen, Yi Guo, et al.
Oncology Letters|August 1, 2018
Colony stimulating factor-1 receptor promotes proliferation, migration and invasion in the human nasopharyngeal carcinoma 6-10B cell line via the phosphoinositide 3-kinase/Akt pathwayJiayu Chen, Yanrong Hao, Jiaxin Chen, et al.
Frontiers in Endocrinology|March 9, 2023
The relationship between metabolic dysfunction-associated fatty liver disease and the incidence rate of extrahepatic cancerSuosu Wei, Yanrong Hao, Xiaofeng Dong, et al.
NPJ Breast Cancer|April 18, 2023
Phase I study of A166, an antibody‒drug conjugate in advanced HER2-expressing solid tumoursJian Zhang, Rujiao Liu, Shuiping Gao, et al.
Pageof 5